Breaking News, Financial News

Financial Report: Sigma-Aldrich

Revenues up 7% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sigma-Aldrich   4Q Revenues: $655 million (+7%) 4Q Earnings: $116 million (+7%) FY Revenues: $2.6 billion (+5%) FY Earnings: $460 million (+1%) Comments: Growth in the quarter was driven by a 3% increase in Research and Sigma-Aldrich Fine Chemicals (SAFC) with sales growth of 2% and 5%, respectively. Acquisitions contributed 6% to sales growth....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters